| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | Rodman David Malcom Chief Medical Officer | Sale | -8,519 | -3.31%63,443 | $24.20 | $206,151 | View SEC filing | |
| 2026-05-19 | Rodman David Malcom Chief Medical Officer | Sale | -417 | -0.65%63,443 | $27.55 | $11,488 | View SEC filing | |
| 2026-05-13 | Rodman David Malcom Chief Medical Officer | Sale | -22,575 | -11.84%63,443 | $28.91 | $652,638 | View SEC filing | |
| 2026-04-21 | Rodman David Malcom Chief Medical Officer | Sale | -416 | -0.59%69,792 | $31.33 | $13,033 | View SEC filing | |
| 2026-04-15 | Rodman David Malcom Chief Medical Officer | Sale | -20,406 | -22.62%69,792 | $26.89 | $548,672 | View SEC filing | |
| 2026-04-15 | Congleton Jon Chief Executive Officer | Sale | -15,730 | -2.23%689,321 | $26.83 | $421,979 | View SEC filing | |
| 2026-04-13 | Rodman David Malcom Chief Medical Officer | Sale | -2,170 | -2.77%76,140 | $27.38 | $59,415 | View SEC filing | |
| 2026-04-02 | Karydas Daphne Director | Sale | -3,000 | -32.61%6,200 | $25.00 | $75,000 | View SEC filing | |
| 2026-04-02 | Congleton Jon Chief Executive Officer | Sale | -75,000 | -9.61%705,051 | $26.27 | $1,970,522 | View SEC filing | |
| 2026-03-31 | RA Capital Healthcare Fund LP Director | Purchase | +369,000 | +6.76%5,825,521 | $23.75 | $8,762,797 | View SEC filing | |
| 2026-03-17 | Rodman David Malcom Chief Medical Officer | Sale | -417 | -0.54%76,140 | $25.65 | $10,696 | View SEC filing | |
| 2026-03-16 | Rodman David Malcom Chief Medical Officer | Sale | -20,406 | -14.29%76,140 | $26.61 | $542,973 | View SEC filing | |
| 2026-03-10 | Rodman David Malcom Chief Medical Officer | Sale | -2,171 | -2.56%82,489 | $26.84 | $58,270 | View SEC filing | |
| 2026-02-17 | Rodman David Malcom Chief Medical Officer | Sale | -417 | -0.94%44,089 | $27.59 | $11,505 | View SEC filing | |
| 2026-02-13 | Rodman David Malcom Chief Medical Officer | Sale | -20,404 | -22.36%44,089 | $27.93 | $569,809 | View SEC filing | |
| 2026-02-11 | Rodman David Malcom Chief Medical Officer | Sale | -2,171 | -4.13%50,437 | $30.21 | $65,586 | View SEC filing | |
| 2026-01-20 | Rodman David Malcom Chief Medical Officer | Sale | -416 | -0.82%50,437 | $32.10 | $13,354 | View SEC filing | |
| 2026-01-15 | Rodman David Malcom Chief Medical Officer | Sale | -19,076 | -27.44%50,437 | $32.66 | $623,115 | View SEC filing | |
| 2026-01-13 | Levy Adam Scott CFO and Secretary | Sale | -10,758 | -55.47%8,638 | $32.14 | $345,723 | View SEC filing | |
| 2026-01-13 | Rodman David Malcom Chief Medical Officer | Sale | -8,518 | -3.39%61,804 | $32.56 | $277,339 | View SEC filing | |
| 2026-01-13 | Congleton Jon Chief Executive Officer | Sale | -16,236 | -2.48%639,151 | $32.62 | $529,640 | View SEC filing | |
| 2026-01-06 | Rodman David Malcom Chief Medical Officer | Sale | -262,752 | -55.61%61,804 | $35.25 | $9,261,028 | View SEC filing | |
| 2025-11-21 | Catalys Pacific Fund, LP 10% Owner | Sale | -1,000,000 | -11.23%7,903,838 | $43.35 | $43,350,000 | View SEC filing | |
| 2025-11-13 | Levy Adam Scott CFO and Secretary | Sale | -119,524 | -86.04%19,396 | $44.88 | $5,363,716 | View SEC filing | |
| 2025-11-13 | Congleton Jon Chief Executive Officer | Sale | -200,000 | -24.06%631,305 | $45.44 | $9,088,499 | View SEC filing |
1-25 of 73
